Reckitt Benckiser Pharmaceuticals Inc.

22 articles about Reckitt Benckiser Pharmaceuticals Inc.

• RB announces $25 million investment in a new Reckitt Global Hygiene Institute to strengthen scientific evidence and achieve behavior change

  7/16/2020

  RB announces the launch of a global initiative to generate high-quality scientific research-based evidence to inform public health recommendations and promote behaviors that improve global hygiene.

• RB Brings Digital R&D Advances to Popular Consumer Products Through Collaboration with Eagle Genomics

  3/19/2020

  Global health and hygiene company RB, maker of Lysol, Air Wick, Mucinex, Enfamil and more, announced a collaboration with life sciences knowledge discovery platform company Eagle Genomics.

• 

  Flurry of Activity: Top 2018 Biopharma M&A Deals So Far

  5/3/2018

  While the biopharma industry awaits news of an acquisition of Shire by Takeda Pharmaceuticals, it’s a good time to take a look back at the bigger deals so far this year.
• 

  Pfizer’s First Quarter Marked by Strong Pipeline, Jump in Profit, but Lower Revenue than Expected

  5/1/2018

  Overall, Pfizer posted a good first quarter, with sales slightly higher and a 14 percent increase in profits due to lower restructuring costs and a significantly lower tax rate. However, revenue was below Wall Street expectations.
• 

  Sanofi to Sell its Generic Division to Advent for $2.4 Billion

  4/17/2018

  Sanofi has agreed to sell its generics division, Zentiva, to Advent International. The deal is expected to wrap by the end of this year.
• 

  Mylan Rumored to be in Discussions to Buy Merck KGaA’s Consumer Health Business, but Mylan Denies It

  4/13/2018

  Mylan is reportedly in top-level talks with Germany’s Merck KGaA to buy its consumer health business. However, Mylan has denied it.
• 

  GSK Walks Away From Acquiring Pfizer Consumer Goods Unit

  3/23/2018

  GlaxoSmithKline has decided not to make a play for Pfizer's consumer health business. The decision came one day after another potential suitor walked away from a potential deal.
• 

  GSK, Reckitt are the Only Suitors for Pfizer's $20B Consumer Health Biz

  2/5/2018

  Companies including Sanofi, J&J, Nestle have dropped out.

• Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment Of Chief Financial Officer

  11/4/2014

• Reckitt Benckiser Pharmaceuticals Inc. Announces Plans To Rebrand Under Indivior PLC Following Demerger

  10/21/2014

• Facebook And Reckitt Benckiser Pharmaceuticals Inc. Partner On Innovative Global Approach To Effectively Reach Consumers In Their Digital Lives

  8/4/2014

• AntiOp Partners With Reckitt Benckiser Pharmaceuticals Inc. To Develop Nasally Administered Treatment For Opioid Overdose

  5/21/2014

• Reckitt Benckiser Pharmaceuticals Inc. Enters Into Agreement To Develop And Market First Naloxone Nasal Treatment For Opioid Overdose

  5/19/2014

• Reckitt Benckiser Pharmaceuticals Inc. Slides As Its Drugs Fail To Take Effect

  12/9/2013

• Reckitt Benckiser Pharmaceuticals Inc. Pharma Unit In The U.S. Is Raided By The Feds

  12/9/2013

• Reckitt Benckiser Pharmaceuticals Inc. Relase: Michael "The Situation" Sorrentino Partners With Community Ambassadors to Show the Reality of Opioid Prescription Painkiller Addiction and Motivate Americans Battling the Disease to "Reset Reality"

  9/10/2013

• Reckitt Benckiser Pharmaceuticals Inc. Disappointed Over FDA Denial

  2/25/2013

• Reckitt Benckiser Pharmaceuticals Inc. Buys Golong Medicine of Anhui, a TCM Maker

  2/25/2013

• FDA Grants Approval for Reckitt Benckiser Pharmaceuticals Inc.'s Suboxone Sublingual Film

  8/20/2012

• Reckitt Benckiser Pharmaceuticals Inc. Release: New Report Puts Spotlight on Epidemic of Painkiller Abuse and Need for Patient Education and Resources

  11/10/2011